Glucotrack Announces 3 New Patents to Monitor Blood Glucose

Glucotrack Announces 3 New Patents to Monitor Blood Glucose

By Karen Roman GlucoTrack, Inc. (Nasdaq: GCTK) said the U.S. Patent and Trademark Office issued three patents for its continuous blood glucose monitoring platform as the company moves toward commercializing it. The three patents protect key technologies related to proprietary...

Input your search keywords and press Enter.